Peter M. Hecht, Chief Executive Officer at Cyclerion Therapeutics, Inc. (CYCN), bought 302,000 shares at $2.43 ($734K) on 2021-05-06, disclosed to the SEC on 2021-05-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IRWD | SELL | 2019-01-25 | $1.1M | — | Filing → |
| IRWD | SELL | 2017-12-08 | $1.7M | — | Filing → |
| IRWD | SELL | 2017-01-13 | $1.6M | — | Filing → |